273 related articles for article (PubMed ID: 2571021)
1. Gamma-hydroxybutyric acid for treatment of alcohol withdrawal syndrome.
Gallimberti L; Canton G; Gentile N; Ferri M; Cibin M; Ferrara SD; Fadda F; Gessa GL
Lancet; 1989 Sep; 2(8666):787-9. PubMed ID: 2571021
[TBL] [Abstract][Full Text] [Related]
2. Suppression by gamma-hydroxybutyric acid of ethanol withdrawal syndrome in rats.
Fadda F; Colombo G; Mosca E; Gessa GL
Alcohol Alcohol; 1989; 24(5):447-51. PubMed ID: 2818752
[TBL] [Abstract][Full Text] [Related]
3. Gamma-hydroxybutyric acid (GHB) in the treatment of alcohol withdrawal syndrome: a randomized comparative study versus benzodiazepine.
Addolorato G; Balducci G; Capristo E; Attilia ML; Taggi F; Gasbarrini G; Ceccanti M
Alcohol Clin Exp Res; 1999 Oct; 23(10):1596-604. PubMed ID: 10549990
[TBL] [Abstract][Full Text] [Related]
4. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses.
Leone MA; Vigna-Taglianti F; Avanzi G; Brambilla R; Faggiano F
Cochrane Database Syst Rev; 2010 Feb; (2):CD006266. PubMed ID: 20166080
[TBL] [Abstract][Full Text] [Related]
5. Double-blind controlled trial of gamma-hydroxybutyrate and clomethiazole in the treatment of alcohol withdrawal.
Nimmerrichter AA; Walter H; Gutierrez-Lobos KE; Lesch OM
Alcohol Alcohol; 2002; 37(1):67-73. PubMed ID: 11825860
[TBL] [Abstract][Full Text] [Related]
6. Gamma-hydroxybutyric acid for treatment of opiate withdrawal syndrome.
Gallimberti L; Cibin M; Pagnin P; Sabbion R; Pani PP; Pirastu R; Ferrara SD; Gessa GL
Neuropsychopharmacology; 1993 Aug; 9(1):77-81. PubMed ID: 8397726
[TBL] [Abstract][Full Text] [Related]
7. Gamma-hydroxybutyric acid versus clomethiazole for the treatment of alcohol withdrawal syndrome in a medical intensive care unit: an open, single-center randomized study.
Elsing C; Stremmel W; Grenda U; Herrmann T
Am J Drug Alcohol Abuse; 2009; 35(3):189-92. PubMed ID: 19462303
[TBL] [Abstract][Full Text] [Related]
8. [Gamma-hydroxybutyrate for treatment of alcohol withdrawal syndrome in intensive care patients. A comparison between with two symptom-oriented therapeutic concepts].
Lenzenhuber E; Müller C; Rommelspacher H; Spies C
Anaesthesist; 1999 Feb; 48(2):89-96. PubMed ID: 10093649
[TBL] [Abstract][Full Text] [Related]
9. Sodium Oxybate Therapy for Alcohol Withdrawal Syndrome and Keeping of Alcohol Abstinence.
Mannucci C; Pichini S; Spagnolo EV; Calapai F; Gangemi S; Navarra M; Calapai G
Curr Drug Metab; 2018; 19(13):1056-1064. PubMed ID: 29219048
[TBL] [Abstract][Full Text] [Related]
10. [Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment].
van Noorden MS; Kamal R; de Jong CA; Vergouwen AC; Zitman FG
Ned Tijdschr Geneeskd; 2010; 154():A1286. PubMed ID: 21040601
[TBL] [Abstract][Full Text] [Related]
11. [Hypernatremia caused by treatment with GHB obtained via a doctor's prescription].
Rood IM; Seijger CG; van Waarde JA; de Maat MM; Verhave JC; Blans MJ
Tijdschr Psychiatr; 2017; 59(1):47-51. PubMed ID: 28098924
[TBL] [Abstract][Full Text] [Related]
12. Long-term γ-hydroxybutyric acid (GHB) and disulfiram combination therapy in GHB treatment-resistant chronic alcoholics.
Maremmani AG; Pani PP; Rovai L; Pacini M; Dell'Osso L; Maremmani I
Int J Environ Res Public Health; 2011 Jul; 8(7):2816-27. PubMed ID: 21845160
[TBL] [Abstract][Full Text] [Related]
13. A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder.
Caputo F; Vignoli T; Tarli C; Domenicali M; Zoli G; Bernardi M; Addolorato G
Int J Environ Res Public Health; 2016 Mar; 13(3):. PubMed ID: 26959045
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawal.
Gallimberti L; Schifano F; Forza G; Miconi L; Ferrara SD
Eur Arch Psychiatry Clin Neurosci; 1994; 244(3):113-4. PubMed ID: 7803523
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of gamma-hydroxybutyrate withdrawal].
Strand NAW; Petersen TS; Nielsen LM; Boegevig S
Ugeskr Laeger; 2017 Dec; 179(50):. PubMed ID: 29260701
[TBL] [Abstract][Full Text] [Related]
16. [Withdrawal syndrome following chronic use of gamma-hydroxybutyric acid (GHB)].
Moitroux A; Kestens C
Rev Med Liege; 2023 Jul; 78(7-8):451-455. PubMed ID: 37560960
[TBL] [Abstract][Full Text] [Related]
17. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration.
Addolorato G; Caputo F; Capristo E; Bernardi M; Stefanini GF; Gasbarrini G
Clin Neuropharmacol; 1999; 22(1):60-2. PubMed ID: 10047936
[TBL] [Abstract][Full Text] [Related]
18. Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review.
Caputo F; Vignoli T; Maremmani I; Bernardi M; Zoli G
Int J Environ Res Public Health; 2009 Jun; 6(6):1917-29. PubMed ID: 19578468
[TBL] [Abstract][Full Text] [Related]
19. The abrupt cessation of therapeutically administered sodium oxybate (GHB) does not cause withdrawal symptoms.
J Toxicol Clin Toxicol; 2003; 41(2):131-5. PubMed ID: 12733850
[TBL] [Abstract][Full Text] [Related]
20. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
Liao PC; Chang HM; Chen LY
J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
